41.3.26: Chapter 27

Pharmacology for Nurses · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY 4.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    41.3.26: Chapter 27

    Case Study

    1. b. This client with hyperthyroidism is showing evidence of toxicity to methimazole. Manifestations of methimazole toxicity are similar to those of hypothyroidism and include cold intolerance, weight gain, fatigue, lack of energy, bradycardia, and depression.
    2. d. TSH, T3, and T4 laboratory tests are used to determine hypothyroidism.

    Review Questions

    1. c. Symptoms of hyperthyroidism include weight loss, heat intolerance, diarrhea, fine tremor, tachycardia, frequent mood changes, and muscle weakness.
    2. d. Clients with hypothyroidism will have an elevated TSH level.
    3. d. Methimazole is an antithyroid drug used to treat hyperthyroidism.
    4. c. Soy has a food interaction with levothyroxine and can decrease its effectiveness.
    5. c. An increase in energy is a therapeutic effect of levothyroxine.
    6. c. The phosphate level is above the expected reference range. Phosphate levels are increased in clients with hypoparathyroidism.
    7. a. Bone pain, along with muscle weakness and depression, are signs of hyperparathyroidism.
    8. a. Alendronate may cause esophagitis, which can lead to dyspepsia.
    9. b. First, convert 0.275 mg to mcg,
    (desired dose) (supply on hand)
    10. b. 15 mg divided by three divided doses equals 5 mg each dose.

    This page titled 41.3.26: Chapter 27 was last modified on Sun, 29 Dec 2024 08:23:52 GMT and is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by OpenStax.